CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus
Jiyun Park, Nammi Park, Sangjin Han, You-Bin Lee, Gyuri Kim, Sang-Man Jin, Woo Je Lee, Jae Hyeon Kim

DOI: https://doi.org/10.4093/dmj.2021.0299

Excel Download

Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation study
Clinical Pharmacology: Advances and Applications. 2014;63   Crossref logo
Link1

Letter: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J2013;37:117-24)
Diabetes & Metabolism Journal. 2013;37(3):212   Crossref logo
Link1 Link2 Link3

Correction to: Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial
Diabetes Therapy. 2021;12(10):2807-2811   Crossref logo
Link1 Link2 Link3

Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
Diabetes Therapy. 2017;8(3):611-621   Crossref logo
Link1 Link2 Link3

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study
Diabetology International. 2018;10(1):37-50   Crossref logo
Link1 Link2 Link3

Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial
Diabetes Therapy. 2021;12(3):863-877   Crossref logo
Link1 Link2 Link3

Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm Study
Diabetes Therapy. 2017;8(3):623-624   Crossref logo
Link1 Link2 Link3

Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension
Diabetes, Obesity and Metabolism. 2013;16(5):418-425   Crossref logo
Link1 Link2

Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study
Diabetes & Metabolism Journal. 2013;37(2):117   Crossref logo
Link1 Link2 Link3

A prospective, open-label, single-arm study to evaluate efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel
Contraception. 2012;86(3):313   Crossref logo
Link1 Link2